Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
How much would you pay to meet a Real Housewife? At BravoCon, the limit does not exist. - 2Overlooked infertility care should be part of national health services, says WHO
- 3Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- 4Motivational Travel Objections for History Buffs
- 5Ski Resorts Universally: A Colder time of year Wonderland Guide
- Dave Coulier reveals he has tongue cancer, his 2nd diagnosis in a year, after beating non-Hodgkin lymphoma
- Kremlin: Russian troops conquer Pokrovsk after year of intense combat
- Find the Abilities Required for Advanced Advertising Position
- Five EU states press for windfall taxes on fossil energy sector
- Going with Children: Tips for Tranquil Family Get-aways
- Newly discovered link between traumatic brain injury in children and epigenetic changes could help personalize treatment for recovering kids
- Figure out How to Take part in Open Conversations Around 5G Pinnacles
- 7 Fun Plans to Make Film Evenings Seriously Invigorating (You'll Cherish #5!)
- Qantas and Virgin Australia Ban Power Bank Usage on Flights Following Safety Incidents
